Enbrel (etanercept subcutaneous injection - Immunex/Amgen) — Cigna

Initial criteria

• Patient age > 18 years
• Medication is prescribed by or in consultation with a rheumatologist

Reauthorization criteria

• Patient has been established on therapy for at least 6 months
• AND patient has experienced a beneficial clinical response from baseline when assessed by at least one objective measure (e.g., ASDAS, BASDAI, BASFI, CRP, ESR) OR patient experienced improvement in at least one symptom (e.g., decreased pain or stiffness, improved function or activities of daily living)

Approval duration

initial 6 months; reauth 1 year